From Wikipedia, the free encyclopedia
Chemical compound
1B-LSD
|
|
Legal status |
|
---|
|
(6aR,9R)-N,N-diethyl-6-methyl-4-butanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
|
CAS Number | |
---|
PubChem
CID | |
---|
ChemSpider | |
---|
UNII | |
---|
|
Formula | C24H31N3O2 |
---|
Molar mass | 393.531 g·mol−1 |
---|
3D model (
JSmol) | |
---|
CN1[C@](C2=C[C@@H](C(N(CC)CC)=O)C1)([H])CC3=CN(C(CCC)=O)C4=C3C2=CC=C4
|
InChI=1S/C24H31N3O2/c1-5-9-22(28)27-15-16-13-21-19(18-10-8-11-20(27)23(16)18)12-17(14-25(21)4)24(29)26(6-2)7-3/h8,10-12,15,17,21H,5-7,9,13-14H2,1-4H3/t17-,21-/m1/s1 Key:SVRFNPSJPIDUBC-DYESRHJHSA-N
|
1B-LSD (N1-butyryl-lysergic acid diethylamide) is an
acylated derivative of
lysergic acid diethylamide (LSD), which has been sold as a
designer drug.
[2] In tests on mice it was found to be an active
psychedelic, though with only around 1/7 the potency of LSD itself.
[3]
[4]
[5]
Legal status
1B-LSD is illegal in
Singapore.
[6]
Sweden's public health agency suggested classifying 1B-LSD as a
hazardous substance, on June 24, 2019.
[7]
See also
References
-
^
"Arrêté du 20 mai 2021 modifiant l'arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants". www.legifrance.gouv.fr (in French). 20 May 2021.
-
^ Tsochatzis E, Lopes JA, Reniero F, Holland M, Åberg J, Guillou C (February 2020).
"Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics". Molecules. 25 (3): 712.
doi:
10.3390/molecules25030712.
PMC
7037844.
PMID
32045999.
-
^ Wagmann L, Richter LH, Kehl T, Wack F, Bergstrand MP, Brandt SD, et al. (July 2019).
"In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures" (PDF).
Analytical and Bioanalytical Chemistry. 411 (19): 4751–4763.
doi:
10.1007/s00216-018-1558-9.
PMID
30617391.
S2CID
58615418.
-
^ Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Dowling G, et al. (August 2019).
"Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD)".
Drug Testing and Analysis. 11 (8): 1122–1133.
doi:
10.1002/dta.2613.
PMC
6899222.
PMID
31083768.
-
^ Halberstadt AL, Chatha M, Klein AK, McCorvy JD, Meyer MR, Wagmann L, et al. (August 2020).
"Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD)" (PDF). Neuropharmacology. 172: 107856.
doi:
10.1016/j.neuropharm.2019.107856.
PMC
9191647.
PMID
31756337.
S2CID
208155327.
-
^
"Misuse of Drugs Act - Singapore Statutes Online". sso.agc.gov.sg.
-
^
"Åtta ämnen föreslås klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. 24 June 2019.
|
---|
Psychedelics (
5-HT2A agonists) |
Benzofurans | |
---|
Lyserg‐ amides | |
---|
Phenethyl‐ amines |
2C-x |
25x-NBx | 25x-
NB | |
---|
25x-
NB3OMe | |
---|
25x-
NB4OMe | |
---|
25x-
NBF | |
---|
25x-
NBMD | |
---|
25x-
NBOH | |
---|
25x-
NBOMe | |
---|
Atypical structures | |
---|
|
---|
25x-NMx | |
---|
N-(2C)-fentanyl | |
---|
|
---|
3C-x | |
---|
4C-x | |
---|
DOx | |
---|
HOT-x | |
---|
MDxx | |
---|
Mescaline (subst.) | |
---|
TMAs |
- TMA
- TMA-2
- TMA-3
- TMA-4
- TMA-5
- TMA-6
|
---|
Others | |
---|
|
---|
Piperazines | |
---|
Tryptamines |
alpha-alkyltryptamines | |
---|
x-
DALT | |
---|
x-
DET | |
---|
x-
DiPT | |
---|
x-
DMT |
-
4,5-DHP-DMT
-
2,N,N-TMT
-
4-AcO-DMT
-
4-HO-5-MeO-DMT
-
4,N,N-TMT
-
4-Propionyloxy-DMT
-
5,6-diBr-DMT
-
5-AcO-DMT
-
5-Bromo-DMT
-
5-MeO-2,N,N-TMT
-
5-MeO-4,N,N-TMT
-
5-MeO-α,N,N-TMT
-
5-MeO-DMT
-
5-N,N-TMT
-
7,N,N-TMT
-
α,N,N-TMT
-
(Bufotenin) 5-HO-DMT
-
DMT
-
Norbaeocystin
-
(Psilocin) 4-HO-DMT
-
(Psilocybin) 4-PO-DMT
|
---|
x-
DPT | |
---|
Ibogaine-related | |
---|
x-
MET | |
---|
x-
MiPT | |
---|
Others | |
---|
|
---|
Others | |
---|
|
---|
Dissociatives (
NMDAR
antagonists) | |
---|
Deliriants (
mAChR
antagonists) | |
---|
Others | |
---|